Mark Bunnage: Absolute delight to have Caroline Fox joining our team to lead Boston Research
Mark Bunnage, Senior Vice President and Head of Research at Vertex Pharmaceuticals, announced on LinkedIn:
“It’s an absolute delight to have Caroline Fox joining our team to lead Boston Research. Caroline’s expertise as a highly accomplished physician-scientist with extensive experience in human disease biology research across both academia and industry is a great fit with Vertex’s passion for scientific innovation targeting the underlying cause of serious diseases.
It’s an exciting time for Boston Research as we continue our work in multiple programs across research and clinical development. Caroline, we’re so glad to have you on the team as we prepare for what’s next in discovery research and beyond. Welcome to Vertex Pharmaceuticals.”
Source: Mark Bunnage/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023